---
title: "China Meheco: The application for the listing of hydrochlorothiazide has been approved"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/247448760.md"
description: "China Meheco's wholly-owned subsidiary Tianfang Pharmaceutical has received approval from the National Medical Products Administration for the marketing application of the chemical raw material drug Urapidil Hydrochloride. This medication is primarily used to treat hypertensive crises, severe and very severe hypertension, as well as resistant hypertension, and can control perioperative hypertension"
datetime: "2025-07-07T08:12:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/247448760.md)
  - [en](https://longbridge.com/en/news/247448760.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/247448760.md)
---

# China Meheco: The application for the listing of hydrochlorothiazide has been approved

According to the announcement from China Meheco (600056.SH), its wholly-owned subsidiary Tianfang Pharmaceutical Co., Ltd. (hereinafter referred to as "Tianfang Pharmaceutical") has recently received the "Approval Notice for the Application for Market Launch of Chemical Raw Materials" for Urapidil Hydrochloride (hereinafter referred to as "the drug") issued by the National Medical Products Administration (hereinafter referred to as "NMPA").

This drug is mainly used for the treatment of hypertensive crises (such as a sudden increase in blood pressure), severe and extremely severe hypertension, and refractory hypertension; it is also used to control perioperative hypertension

### Related Stocks

- [600056.CN](https://longbridge.com/en/quote/600056.CN.md)

## Related News & Research

- [EXPLAINER-What is Unitree and why are China’s humanoid robot makers racing to list?](https://longbridge.com/en/news/295349610.md)
- [Unitree IPO Frenzy Leaves Retail Investors Scrambling as Over 70% of Shares Go to Institutions](https://longbridge.com/en/news/295656794.md)
- [FDA Issues Warning About Certain Products Containing Toxic Yellow Oleander](https://longbridge.com/en/news/295690341.md)
- [Humanwell unit Yichang Renfu wins China nod for labor pain trial of sufentanil injection](https://longbridge.com/en/news/295637927.md)
- [15:03 ETMNA: MGB Refuses to Schedule More Negotiations or Make Any Proposals to Brigham Nurses in Third Session Following Historic Strike](https://longbridge.com/en/news/295569711.md)